Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)

Salicylates are interference compounds in TR-FRET assays

(2016) Ronan P. Hanley et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18

(2016) Silvia Carvalho et al.   BRITISH JOURNAL OF PHARMACOLOGY

PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease

(2016) Kuti Baruch et al.   NATURE MEDICINE

Blocking of the PD-1/PD-L1 Interaction by aD-Peptide Antagonist for Cancer Immunotherapy

(2015) Hao-Nan Chang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

PD-1 Blockers

(2015) Jedd D. Wolchok   CELL

Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging

(2015) Roy L. Maute et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1

(2015) Krzysztof M. Zak et al.   STRUCTURE

Programmed Death-1: Therapeutic Success after More than 100 Years of Cancer Immunotherapy

(2014) Alexander Dömling et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

PD-1 and Its Ligands in Tolerance and Immunity

(2008) Mary E. Keir et al.   Annual Review of Immunology